Clinical Study
Pancreatic Stenting Reduces Post-ERCP Pancreatitis and Biliary Sepsis in High-Risk Patients: A Randomized, Controlled Study
Table 1
Baseline demographic and clinical characteristics of patients.
| | Experimental group () | Control group () | |
| Age, year, mean ± SD | 57.2 ± 14.4 | 57.4 ± 13.9 | 0.924 | Sex, male/female | 59/45 | 55/47 | 0.685 | ERCP indications, (%) | | | | CBD gallstone | 72 (69.2) | 60 (58.8) | 0.120 | Bile duct dilation | 3 (2.9) | 5 (4.9) | 0.454 | Cholangitis | 2 (1.9) | 1 (1.0) | 0.572 | Malignant CBD stricture | 24 (23.1) | 34 (33.3) | 0.102 | Pancreatic cancer | 9 (8.7) | 4 (3.9) | 0.163 | Duodenal papillitis | 2 (1.9) | 1 (1.0) | 0.572 | Sclerosing cholangitis | 1 (1.0) | 1 (1.0) | 0.989 | Concomitant liver fluke disease, (%) | 31 (29.8) | 32 (31.4) | 0.807 | Complicating risk factors, (%) | | | | Complicating 2 risk factors | 22 (21.2) | 29 (28.4) | 0.226 | Complicating 3 risk factors | 25 (24.0) | 32 (31.4) | 0.239 | Complicating 4 risk factors | 38 (36.5) | 25 (24.5) | 0.061 | Complicating ≥ 5 risk factors | 19 (18.3) | 16 (15.7) | 0.622 |
|
|